Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 2055 of 6351
-
A Parent's smartphone video could be a new tool to screen kids for sleep apnea
Diagnosis Stopped earlyThe aim of the study is to evaluate the value of a video recording of the child sleep on smartphone made by the parents and comparing it to ventilatory polygraphy (PV) on the one hand and to the clinical evaluation method (clinical examination + Spruyt and Gozal score) on the oth…
Sponsor: University Hospital, Clermont-Ferrand • Aim: Diagnosis
Last updated Aug 08, 2026 00:03 UTC
-
Could less radiation be just as good for lymphoma?
Disease control OngoingThis phase II study will evaluate whether a reduction in radiation dose and field size will maintain a high rate of local control while minimizing the risk of acute and late toxicity . Hypothesis: The radiation dose and treatment volume can be safely reduced from 30 Gy to 20 Gy …
Sponsor: Duke University • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
New combo therapy shows promise for tough prostate cancers
Disease control CompletedAn open-label, multicenter, Phase 1b/2 study to identify the recommended Phase 2 dose and assess the efficacy and safety of BXCL701 administered orally, as monotherapy and in combination with PEMBRO, in patients with mCRPC. Patients enrolled in the Phase 2a portion of the study w…
Phase 1/2 • Sponsor: BioXcel Therapeutics Inc • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
Cold virus hijacked to attack returning brain tumors in early trial
Disease control Recruiting nowThis phase I trial studies best dose and side effects of oncolytic adenovirus DNX-2401 in treating patients with high-grade glioma that has come back (recurrent). Oncolytic adenovirus DNX-2401 is made from the common cold virus that has been changed in the laboratory to make it l…
Phase 1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
Gene test may help prevent deadly fungal infections in leukemia patients
Disease control Recruiting nowThis is a prospective genetically-stratified randomized double-blind event-driven multicentre clinical trial to assess the efficacy of posaconazole-based antifungal prophylaxis allocation strategies for patients with acute myeloid leukemia who receive induction chemotherapy. Allo…
Sponsor: Bochud Pierre-Yves • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Texts and home visits aim to stop repeat STIs in young women
Prevention OngoingThe investigators are enrolling 150 young women 13-25 years old diagnosed with pelvic inflammatory disease (PID) in Baltimore to receive community health nurse (CHN) clinical support visits and short messaging system communication support for 30 days. The investigators' intervent…
Sponsor: Johns Hopkins University • Aim: Prevention
Last updated Jun 27, 2026 07:57 UTC
-
Could a common drug make radiation deadlier to lung tumors?
Disease control OngoingThis phase I trial studies the side effects and how well papaverine hydrochloride and stereotactic radiation therapy body (SBRT) work in treating patients with non-small cell lung cancer. Papaverine hydrochloride may help radiation therapy work better by making tumor cells more s…
Phase 1 • Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Can a phone app decode chronic pain?
Knowledge-focused CompletedChronic pain affects approximately 20% of adults, 50% of the elderly population and over 1.5 billion people worldwide. Societal and economic issues are also crucial, as 60% of people with pain are less able or unable to work and 20% say they have lost their jobs because of pain. …
Sponsor: University Hospital, Clermont-Ferrand • Aim: Knowledge-focused
Last updated Aug 12, 2026 00:00 UTC
-
New drug targets Hard-to-Treat prostate cancer in early trial
Disease control Stopped earlyA phase 1 study evaluating the safety, tolerability, pharmacokinetics, and efficacy of prostate specific membrane antigen half-life extended bispecific T-cell engager acapatamab in subjects with metastatic castration-resistant prostate cancer, and to determine the maximum tolerat…
Phase 1 • Sponsor: Amgen • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
New catheter device aims to fix leaky heart valve without cutting chest
Disease control CompletedEarly feasibility study to assess the safety and performance of the Edwards PASCAL Transcatheter Valve Repair System in tricuspid regurgitation
Sponsor: Edwards Lifesciences • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
New drug combo shows promise for Hard-to-Treat breast cancer
Disease control OngoingThe standard or usual treatment for this disease is to undergo chemotherapy to slow the spread of disease and relieve some symptoms of cancer. One of the standard types of chemotherapy is a drug called paclitaxel (Taxol) given in a low dose every week for three out of four weeks.…
Phase 1/2 • Sponsor: Canadian Cancer Trials Group • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
Experimental drug aims to heal painful fistulas in Crohn's patients
Disease control CompletedThis is a study in adults with Crohn's Disease who also have fistulas near the anus. The study has 2 parts. The first part is to find out more about what causes the fistulas. In this part of the study, tissue samples are taken from patients. The second part of the study tests whe…
Phase 2 • Sponsor: Boehringer Ingelheim • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
Balloon trick during heart attack may cut death risk
Disease control Recruiting nowIn a prospective, randomized clinical trial the iPOST2 trial will determine whether ischemic postconditioning reduces reperfusion injury and this will translate into improved clinical outcome of heart failure and death for STEMI patients who present with TIMI0-1 undergoing primar…
Sponsor: Rigshospitalet, Denmark • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
Can the HPV vaccine protect those with a weak immune system?
Vaccine OngoingBackground: Diseases related to human papillomavirus (HPV) include warts, lesions, and cancers. ICL is idiopathic CD4 T cell lymphocytopenia. People with this rare disease get more HPV-related diseases than other people do. The diseases are more severe and harder to treat in peo…
Phase 2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Vaccine
Last updated Aug 19, 2026 00:00 UTC
-
New combo shows promise for rare blood cancer
Disease control OngoingThis phase I/II trial studies the side effects and best dose of pralatrexate when given together with pembrolizumab and how well they work in treating patients with peripheral T-cell lymphomas that has come back after a period of improvement or has not responded to treatment. Pra…
Phase 1/2 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
A closer look: could hysteroscopy guide better repair of cesarean scar defects?
Knowledge-focused CompletedCesarean section scar defects (CSDs) are one of the long-term complications following cesarean section. They can be detected by transvaginal sonography, hysterosalpingography, sonohysterography and magnetic resonance imaging (MRI). Hysteroscopy is frequently used in evaluating en…
Sponsor: Xinhua Hospital, Shanghai Jiao Tong University School of Medicine • Aim: Knowledge-focused
Last updated Aug 15, 2026 00:00 UTC
-
Can your diet and gut bacteria influence lung cancer survival?
Knowledge-focused Recruiting nowModifiable risk factors, including smoking, alcohol consumption, and diet, play critical roles in cancer progression and patient prognosis. In patients diagnosed with lung cancer, these risk factors not only directly modulate host metabolism and immune regulation, but also exert …
Sponsor: Shengjing Hospital • Aim: Knowledge-focused
Last updated Aug 23, 2026 00:00 UTC
-
New drug MR13A9 shows promise for Dialysis-Related itching
Symptom relief CompletedDouble-blind, Placebo-controlled study to evaluate the dose-response relationship of safety, efficacy and pharmacokinetics of MA13A9 in hemodialysis patients with pruritus.
Phase 2 • Sponsor: Kissei Pharmaceutical Co., Ltd. • Aim: Symptom relief
Last updated Jun 27, 2026 08:02 UTC
-
New scan could reveal if chemo is working in just weeks
Diagnosis OngoingThis research study is evaluating whether the use of digital breast tomosynthesis and near-infrared tomographic optical breast imaging (DBT-TOBI) scans can predict the response of triple negative or HER2+ breast cancer to neoadjuvant chemotherapy. The study radiologic scan invol…
Sponsor: Massachusetts General Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 12:04 UTC
-
Could a blood chemical explain bone pain in breast cancer?
Knowledge-focused Stopped earlyThis trial studies histamine and bone pain association in participants with breast cancer that has spread to the bone. Studying histamine levels in samples of blood from participants with breast cancer in the laboratory may help doctors learn more about reducing cancer bone pain …
Sponsor: Wake Forest University Health Sciences • Aim: Knowledge-focused
Last updated Aug 05, 2026 00:00 UTC